Arora, Himanshu http://orcid.org/0000-0003-3143-6387
Qureshi, Rehana
Khodamoradi, Kajal
Seetharam, Deepa
Parmar, Madhumita
Van Booven, Derek J.
Issa, Isabelle Catherine
Sackstein, Robert
Lamb, Dolores
Hare, Joshua M. http://orcid.org/0000-0002-7751-5032
Ramasamy, Ranjith
Funding for this research was provided by:
Northeastern Section of the American Urological Association
Article History
Received: 2 August 2021
Revised: 1 February 2022
Accepted: 16 February 2022
First Online: 4 March 2022
Competing interests
: JMH is the Chief Scientific Officer, a compensated consultant, and advisory board member for Longeveron and holds equity in Longeveron, is also the co-inventor of intellectual property licensed to Longeveron, holds equity in Vestion and maintains a compensated professional relationship with Vestion as a consultant and member of the Board of Directors and Scientific Advisory Board, is the co-inventor of intellectual property licensed to Vestion for use in this study, is a scientific co-founder and uncompensated consultant and advisory board member for Heart Genomics and holds equity in Heart Genomics, and is also the co-inventor of intellectual property licensed to Heart Genomics. DJL discloses, she is the secretary-treasurer and executive board member at the American Board of Bioanalysts and American Association of Bioanalysts, is also in the editorial board for the WHO laboratory manual for the examination and processing of human semen Sixth edition and receives travel expenses to board meetings in Geneva, serves on the advisory board of Celmatix Scientific and receives no financial compensation, has equity in the Fellow Health Scientific advisory board, and participates in Roman Health where she receives equity and compensation for Consultation and Advisorship. The authors declare no competing interests.
: All authors have provided their consent for publication.